Search

Meeting Coverage:

American Society of Retina Specialists Annual Meeting

ASRS: 2015

Ranibizumab in the Treatment of Extra Large PEDs: Do the Benefits Outweigh the Risks?

David A. Eichenbaum, MD, Manish Nagpal, MS, DO, FRCS

Show Description +

David A. Eichenbaum, MD, of Retina Vitreous Associates of Florida, talks about his post hoc analysis of the HARBOR trial. He discusses the effects of ranibizumab on pigment epithelial detachment (PED) height, visual acuity, and incidence of retinal pigment epithelial tears in the four patient groups.

Posted: 7/10/2015

Up Next

Intravitreal Injections: Do They Induce Trauma to the Lens?

Intravitreal Injections: Do They Induce Trauma to the Lens?

Paul Hahn, MD, PhD, Steven Yeh, MD

A Post Hoc Analysis of the RISE and RIDE Studies

A Post Hoc Analysis of the RISE and RIDE Studies

J. Michael Jumper, MD, Steven Yeh, MD

Anti-VEGF Treatment of Diabetic Macular Edema in Clinical Practice

Anti-VEGF Treatment of Diabetic Macular Edema in Clinical Practice

Steven Yeh, MD, Kevin J. Blinder, MD

OSPREY and OWL: A Pair of Phase 2 Clinical Trials Evaluating RTH258 for Neovascular AMD

OSPREY and OWL: A Pair of Phase 2 Clinical Trials Evaluating RTH258 for Neovascular AMD

Rishi P. Singh, MD

Complications Associated with PVR Surgery: New Approaches

Complications Associated with PVR Surgery: New Approaches

David A. Eichenbaum, MD, Manish Nagpal, MS, DO, FRCS

Preview to the ASRS Annual Meeting in Vienna

Preview to the ASRS Annual Meeting in Vienna

Carl Regillo, MD, Jonathan L. Prenner, MD

Vitrectomy for DME in Treatment-Naïve Eyes

Vitrectomy for DME in Treatment-Naïve Eyes

Jerzy Nawrocki, MD, PhD, Steven Yeh, MD

C3F8: A Good Alternative Treatment for Macular Holes and VMT

C3F8: A Good Alternative Treatment for Macular Holes and VMT

Calvin E. Mein, MD, Francesco Boscia, MD

25-Gauge Vitrectomy in Foveal Macular Schisis in High Myopes

25-Gauge Vitrectomy in Foveal Macular Schisis in High Myopes

Calvin E. Mein, MD, Francesco Boscia, MD

Back to All Videos

Ranibizumab in the Treatment of Extra Large PEDs: Do the Benefits Outweigh the Risks?

David A. Eichenbaum, MD, Manish Nagpal, MS, DO, FRCS

David A. Eichenbaum, MD, of Retina Vitreous Associates of Florida, talks about his post hoc analysis of the HARBOR trial. He discusses the effects of ranibizumab on pigment epithelial detachment (PED) height, visual acuity, and incidence of retinal pigment epithelial tears in the four patient groups.

Posted: 7/10/2015

Please log in to leave a comment.

Comments

Ameen Marashi

10 years ago

In your opinion which Is better for PED ranibizumab or Afliberecept???!

More From ASRS: 2015 Coverage

Vitrectomy for DME in Treatment-Naïve Eyes

Vitrectomy for DME in Treatment-Naïve Eyes

Jerzy Nawrocki, MD, PhD, Steven Yeh, MD

C3F8: A Good Alternative Treatment for Macular Holes and VMT

C3F8: A Good Alternative Treatment for Macular Holes and VMT

Calvin E. Mein, MD, Francesco Boscia, MD

25-Gauge Vitrectomy in Foveal Macular Schisis in High Myopes

25-Gauge Vitrectomy in Foveal Macular Schisis in High Myopes

Calvin E. Mein, MD, Francesco Boscia, MD

Intravitreal Injections: Do They Induce Trauma to the Lens?

Intravitreal Injections: Do They Induce Trauma to the Lens?

Paul Hahn, MD, PhD, Steven Yeh, MD

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2015.